Altimmune, Inc. (ALT) financial statements and ratios from SEC XBRL: revenue $41000.00 (TTM), net margin -214861.0%, revenue growth 105.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $41000.00 |
| Net Margin | -214861.0% |
| Revenue Growth (YoY) | 105.0% |
| EPS Growth (YoY) | -25.4% |
| Price / Book | 1.27 |
| Price / Sales | 58.34 |
| FCF Yield | -22.4% |
| Altman Z-Score | 1.16 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ALT overview · ALT earnings · ALT KPIs · ALT investor relations · ALT ownership · ALT peers · ALT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.